Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipopolysaccharides as complement inhibitors by complex formation with the purified third complement component (C3).

H U Beuscher, V Brade

    Immunobiology
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Molecular biological detection of pathogens in patients with sepsis. Potentials, limitations and perspectives].

    Der Anaesthesist·2008
    Same author

    [Subcutaneous emphysema of unusual extent].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2007
    Same author

    Leprosy in a pregnant woman.

    Infection·2007
    Same author

    [Spontaneous gas gangrene in a diabetic patient with Clostridium septicum].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2005
    Same author

    Zoonotic Babesia: possibly emerging pathogens to be considered for tick-infested humans in Central Europe.

    International journal of medical microbiology : IJMM·2004
    Same author

    Selection of ketolide resistance in Staphylococcus aureus.

    International journal of antimicrobial agents·2003

    Lipopolysaccharides (LPS) from gram-negative bacteria inhibit complement component C3 activity. This inhibition, mediated by LPS-C3 complex formation, suggests LPS may act as local complement inhibitors at infection sites.

    Area of Science:

    • Immunology
    • Microbiology
    • Biochemistry

    Background:

    • Gram-negative bacteria possess lipopolysaccharides (LPS) on their outer membrane.
    • Complement component C3 is crucial for initiating the complement cascade, a key part of the innate immune system.

    Purpose of the Study:

    • To investigate the inhibitory effect of various bacterial lipopolysaccharides (LPS) on hemolytic complement component C3 activity.
    • To elucidate the mechanism and binding characteristics of LPS-C3 interactions.

    Main Methods:

    • Incubation of purified C3 with LPS from different bacterial strains (smooth and rough forms).
    • Electron microscopy to visualize LPS structure and aggregation.
    • Assessing C3 inhibition and binding capacity under varying conditions.

    Related Experiment Videos

    Main Results:

    • LPS strongly inhibited hemolytic C3 activity, with reactivity dependent on LPS physical state (strand-like aggregates being most potent).
    • Core-deficient LPS retained reactivity, while lipid A alone did not inhibit C3.
    • Inhibition resulted from hydrophobic complex formation between LPS and C3, with significant binding capacities observed for LPS-R and LPS-S.

    Conclusions:

    • Lipopolysaccharides can inhibit complement component C3 activity through complex formation.
    • The physical structure of LPS is critical for its inhibitory effect on C3.
    • LPS may function as local inhibitors of the complement cascade at sites of gram-negative bacterial infection.